These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 22393961)

  • 1. Endostar combined with chemotherapy versus chemotherapy alone for advanced NSCLCs: a meta-analysis.
    Ge W; Cao DD; Wang HM; Jie FF; Zheng YF; Chen Y
    Asian Pac J Cancer Prev; 2011; 12(11):2901-7. PubMed ID: 22393961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endostar combined with chemotherapy versus chemotherapy alone for advanced NSCLCs: a meta-analysis.
    Ge W; Cao DD; Wang HM; Jie FF; Zheng YF; Chen Y
    Asian Pac J Cancer Prev; 2011; 12(10):2705-11. PubMed ID: 22320978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Efficacy and safety of rh-endostatin combined with chemotherapy versus chemotherapy alone for advanced NSCLC: a meta-analysis review].
    Cao D; Ge W; Wang H; Zhang L; Zheng Y; Zhang J
    Zhongguo Fei Ai Za Zhi; 2011 May; 14(5):404-13. PubMed ID: 21569645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endostar (rh-endostatin) versus placebo in combination with vinorelbine plus cisplatin chemotherapy regimen in treatment of advanced non-small cell lung cancer: A meta-analysis.
    An J; Lv W
    Thorac Cancer; 2018 May; 9(5):606-612. PubMed ID: 29575575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A multicenter, randomized, double-blind, placebo-controlled safety study to evaluate the clinical effects and quality of life of paclitaxel-carboplatin (PC) alone or combined with endostar for advanced non-small cell lung cancer (NSCLC)].
    Han BH; Xiu QY; Wang HM; Shen J; Gu AQ; Luo Y; Bai CX; Guo SL; Liu WC; Zhuang ZX; Zhang Y; Zhao YZ; Jiang LY; Shi CL; Jin B; Zhou JY; Jin XQ
    Zhonghua Zhong Liu Za Zhi; 2011 Nov; 33(11):854-9. PubMed ID: 22335953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy of paclitaxel-carboplatin alone or with endostar for advanced non-small cell lung cancer.
    Han B; Xiu Q; Wang H; Shen J; Gu A; Luo Y; Bai C; Guo S; Liu W; Zhuang Z; Zhang Y; Zhao Y; Jiang L; Zhou J; Jin X
    J Thorac Oncol; 2011 Jun; 6(6):1104-9. PubMed ID: 21532504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Efficacy of endostar combined with chemotherapy in multi-cycle treatment of patients with advanced non-small cell lung cancer].
    Li N; Jin ZL; Liu ZJ; Wang J; Li K
    Zhonghua Zhong Liu Za Zhi; 2011 Dec; 33(12):937-42. PubMed ID: 22340106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Evaluation of Durative Transfusion of Endostar Combined with Chemotherapy in Patients with Advanced Non-Small Cell Lung Cancer.
    Li X; Gu G; Soliman F; Sanders AJ; Wang X; Liu C
    Chemotherapy; 2018; 63(4):214-219. PubMed ID: 30347389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic review and meta-analysis of Endostar (rh-endostatin) combined with chemotherapy versus chemotherapy alone for treating advanced non-small cell lung cancer.
    Rong B; Yang S; Li W; Zhang W; Ming Z
    World J Surg Oncol; 2012 Aug; 10():170. PubMed ID: 22917490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endostar continuous versus intermittent intravenous infusion combined with chemotherapy for advanced NSCLC: a systematic review and meta-analysis including non-randomized studies.
    Wang B; Xu L; Li Q; Man S; Jin C; Liu L; Zhan S; Ning Y
    BMC Cancer; 2020 Oct; 20(1):1021. PubMed ID: 33087103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A meta-analysis of platinum plus docetaxel or vinorelbine in the first-line treatment of advanced non-small cell lung cancer].
    Liu T; Wu H; Zhuang X; Lu D; Cai R; Wang W
    Zhongguo Fei Ai Za Zhi; 2014 Apr; 17(4):327-35. PubMed ID: 24758908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The efficacy and safety of continuous intravenous infusion of rh-endostatin combined with platinum-based doublet chemotherapy for advanced non-small-cell lung cancer.
    Liu X; Guo Z; Su L; Zuo A; Gao M; Ji X; Lu J; Yang S; Jiang Y; Lu D
    Invest New Drugs; 2024 Jun; 42(3):309-317. PubMed ID: 38700579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of rh-endostatin (Endostar) combined with pemetrexed/cisplatin followed by rh-endostatin plus pemetrexed maintenance in non-small cell lung cancer: A retrospective comparison with standard chemotherapy.
    Zhou S; Zuo L; He X; Pi J; Jin J; Shi Y
    Thorac Cancer; 2018 Nov; 9(11):1354-1360. PubMed ID: 30152052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Efficacy and safety of rh-endostatin combined with docetaxel in second-line or intolerant toxicity for first-line treatment in patients with advanced non-small cell lung cancer].
    Wang J; Li K; Sun T; Zhang MJ; Li WL; Yao Q; Liu W; Ding CM; He ZY; Mao WD; Wang HM; Zhang Y; Zhou XL
    Zhonghua Zhong Liu Za Zhi; 2013 Aug; 35(8):618-22. PubMed ID: 24314222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of adding rh-endostatin to first-line chemotherapy in patients with advanced non-small-cell lung cancer in China.
    Wu B; Chen H; Shen J; Ye M
    Clin Ther; 2011 Oct; 33(10):1446-55. PubMed ID: 21992806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A meta-analysis of recombinant human endostatin combined with NP regimen for treating non-small cell lung cancer.
    Gao C; Gao C; Yuan Q
    Medicine (Baltimore); 2024 May; 103(21):e38027. PubMed ID: 38788043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of recombinant human endostatin during peri-radiotherapy period in advanced non-small-cell lung cancer.
    Zhu J; Chen G; Niu K; Feng Y; Xie L; Qin S; Wang Z; Li J; Lang S; Zhuo W; Chen Z; Sun J
    Future Oncol; 2022 Mar; 18(9):1077-1087. PubMed ID: 34986655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment on the Efficacy and Safety of Aidi Injection Combined with Vinorelbine and Cisplatin for Treatment of Advanced Nonsmall Cell Lung Cancer.
    Zhao HY; Zhou HY; Wang YT; Chen W; Qi SY; Cao JL; Li GH
    Chin Med J (Engl); 2016 Mar; 129(6):723-30. PubMed ID: 26960377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Real-world treatment pattern and comprehensive comparative effectiveness of Endostar plus different chemotherapy in advanced patients with non-small cell lung cancer.
    Jiang W; Sun W; Li W; Gao J; Wang H; Zhou W; Liang J; Aa L; Wang L
    Sci Rep; 2022 Jun; 12(1):10841. PubMed ID: 35761010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant human endostatin combined with chemotherapy for advanced squamous cell lung cancer: a meta-analysis.
    Feng L; Wang Z; Jing L; Zhou Z; Shi S; Deng R; Liu Y; Meng Q
    World J Surg Oncol; 2021 Feb; 19(1):64. PubMed ID: 33637113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.